Norway Diabetic Foot Ulcer Treatment Market Size & Outlook
Norway diabetic foot ulcer treatment market, 2018-2030 (US$M)
Related Markets
Norway diabetic foot ulcer treatment market highlights
- The Norway diabetic foot ulcer treatment market generated a revenue of USD 88.3 million in 2023 and is expected to reach USD 126.7 million by 2030.
- The Norway market is expected to grow at a CAGR of 5.3% from 2024 to 2030.
- In terms of segment, biologics was the largest revenue generating treatment in 2023.
- Therapy Devices is the most lucrative treatment segment registering the fastest growth during the forecast period.
Diabetic foot ulcer treatment market data book summary
| Market revenue in 2023 | USD 88.3 million |
| Market revenue in 2030 | USD 126.7 million |
| Growth rate | 5.3% (CAGR from 2023 to 2030) |
| Largest segment | Biologics |
| Fastest growing segment | Therapy Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
| Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
Other key industry trends
- In terms of revenue, Norway accounted for 1.7% of the global diabetic foot ulcer treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK diabetic foot ulcer treatment market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 443.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Diabetic Foot Ulcer Treatment Market Scope
Diabetic Foot Ulcer Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway diabetic foot ulcer treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.47% in 2023. Horizon Databook has segmented the Norway diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
The growth can be attributed to rising geriatric population and increasing number of people suffering from several disorders, such as obesity & diabetes. According to Statistics Norway, the population aged above 70 years was calculated to be 670,000 and is estimated to reach around 1.4 million by 2060.
As geriatric population is more susceptible & prevalent to wounds & ulcers, the demand for diabetic foot ulcer treatment products in Norway is anticipated to increase over the forecast period. Norway presents a lucrative opportunity to companies operating in the diabetic foot ulcer treatment market.
Presence of major players in Europe and increasing awareness among the common public are further expected to encourage companies to invest in Norway. This may increase the competitive rivalry among players.
Reasons to subscribe to Norway diabetic foot ulcer treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway diabetic foot ulcer treatment market databook
-
Our clientele includes a mix of diabetic foot ulcer treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway diabetic foot ulcer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Norway diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway diabetic foot ulcer treatment market size, by treatment, 2018-2030 (US$M)
Norway Diabetic Foot Ulcer Treatment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
